Clinical Trial Update: Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating vitamin D3 (cholecalciferol) for delaying the diagnosis of multiple sclerosis after a clinically isolated syndrome has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Cholecalciferol (Vitamin D3) (cholecalciferol)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED